Cargando…

Stewardship of COVID-19 volunteers by nested trial design

Detalles Bibliográficos
Autores principales:	Gottlieb, Robert L, Razonable, Raymund R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255946/ https://www.ncbi.nlm.nih.gov/pubmed/35803288 http://dx.doi.org/10.1016/S1473-3099(22)00429-7

Ejemplares similares

Nested ecology and emergence in pandemics
por: Jenkins, Aaron, et al.
Publicado: (2020)

The FAIR Guiding Principles for scientific data management and stewardship
por: Wilkinson, Mark D., et al.
Publicado: (2016)

Editorial: Neutralizing Antibodies in the Prevention and Treatment of COVID-19
por: Razonable, Raymund R., et al.
Publicado: (2022)

Breaking new ground in antimicrobial stewardship in companion animal veterinary practice
por: Brodbelt, David
Publicado: (2021)

Antimicrobial stewardship in primary health care programs in humanitarian settings: the time to act is now
por: Truppa, Claudia, et al.
Publicado: (2023)

COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
por: Dhand, Abhay, et al.
Publicado: (2022)

The contribution of the observational research design to COVID-19 research
por: Kim, Alfred H J, et al.
Publicado: (2020)

COVID-19, community trials, and inclusion
por: Gill, Paramjit S, et al.
Publicado: (2021)

COVID-19 vaccine design: the Janus face of immune enhancement
por: Hotez, Peter J., et al.
Publicado: (2020)

Rethinking cancer clinical trials for COVID-19 and beyond
por: Doherty, Gary J., et al.
Publicado: (2020)

The COVID-19 pandemic: a catalyst to improve clinical trials
por: Gaba, Prakriti, et al.
Publicado: (2020)

Anticoagulation in COVID-19: reaction to the ACTION trial
por: Berger, Jeffrey S, et al.
Publicado: (2021)

US COVID-19 clinical trial leadership gender disparities
por: Sehgal, Neil K R, et al.
Publicado: (2023)

COVID-19 vaccine trials should seek worthwhile efficacy
por: Krause, Philip, et al.
Publicado: (2020)

Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential
por: Krause, Philip R, et al.
Publicado: (2020)

COVID-19: ACT trials for colchicine and antithrombotic therapies
por: Barco, Stefano, et al.
Publicado: (2022)

PIONEER trial: favipiravir to treat moderate COVID-19
por: Shalhoub, Sarah
Publicado: (2023)

Haemoperfusion should only be used for COVID-19 in the context of randomized trials
por: Clark, Edward G., et al.
Publicado: (2020)

Clinical trials of disease stages in COVID 19: complicated and often misinterpreted
por: Park, Jay J H, et al.
Publicado: (2020)

Clinical Prioritization of Antispike Monoclonal Antibody Treatment of Mild to Moderate COVID-19
por: Razonable, Raymund R., et al.
Publicado: (2022)

Designing circulating tumor DNA-based interventional clinical trials in oncology
por: Araujo, Daniel V., et al.
Publicado: (2019)

Mitigating the impacts of COVID-19: where are the mental health trials?
por: Gilbody, Simon, et al.
Publicado: (2021)

PRINCIPLE: a community-based COVID-19 platform trial
por: Macleod, John, et al.
Publicado: (2021)

From routine data collection to policy design: sex and gender both matter in COVID-19
por: Evagora-Campbell, Mireille, et al.
Publicado: (2021)

Challenges in operationalising clinical trials in India during the COVID-19 pandemic
por: Bassi, Abhinav, et al.
Publicado: (2022)

COVID-19 vaccines: breaking record times to first-in-human trials
por: Kim, Young Chan, et al.
Publicado: (2020)

A negative trial for vasoactive intestinal peptide in COVID-19-associated acute hypoxaemic respiratory failure
por: Lee, Warren L, et al.
Publicado: (2023)

Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic
por: de Paula, Bruno H R, et al.
Publicado: (2020)

An immunological autobiography: my year as a COVID-19 vaccine trial participant
por: Kedl, Ross M.
Publicado: (2022)

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
por: Feldmann, Marc, et al.
Publicado: (2020)

Encouraging results from phase 1/2 COVID-19 vaccine trials
por: Bar-Zeev, Naor, et al.
Publicado: (2020)

Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
por: Robinson, Philip C, et al.
Publicado: (2020)

COVID-19 and the anti-lessons of history
por: Peckham, Robert
Publicado: (2020)

Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge
por: Bierle, Dennis M., et al.
Publicado: (2021)

Early-phase clinical trials in a pandemic: learning from the response to COVID-19
por: Horsley, Alex, et al.
Publicado: (2022)

Subcutaneous interferon beta-1a in COVID-19: raking the ashes of an intervention trial
por: Wilkinson, Tom
Publicado: (2021)

Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
por: Razonable, Raymund R.
Publicado: (2011)

Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs
por: Krishna, Sanjeev, et al.
Publicado: (2022)

COVID-19, climate change, and communities
por: Sacks, Emma, et al.
Publicado: (2021)

Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial
por: Kalil, Andre C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_49qog2l9rm2722lu22drt6vnee